Lion Biotechnologies, Inc. — Form D

Lion Biotechnologies, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2011-08-09. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Dr. William Stephen AndrewsDirectorLOS ANGELES, CA
Anthony CataldoDirectorBeverly Hills, CA
Dr. L. Stephen ColesDirectorLOS ANGELES, CA
Michael HandelmanDirectorBeverly Hills, CA
Merrill A McPeakDirectorKNOXVILLE, TN
Martin A SchroederDirectorLOS ANGELES, CA
David A VoytickyDirectorLOS ANGELES, CA
Anthony CataldoExecutive OfficerBeverly Hills, CA
Jay VenkatesanDirectorBoston, MA
Maria FardisDirectorSan Francisco, CA
Maria FardisExecutive OfficerSan Francisco, CA
Paul KesslerDirectorLos Angeles, CA
Sanford J HillsbergDirectorLos Angeles, CA
Molly C HendersonExecutive OfficerNew York, NY
Michael T LotzeExecutive OfficerNew York, NY
Merrill McPeakDirectorNew York, NY
Merrill McPeakExecutive OfficerNew York, NY
Steven A FischkoffExecutive OfficerNew York, NY
Wayne J RothbaumDirectorNew York, NY
Ryan J MaynardDirectorNew York, NY
Michael HandelmanExecutive OfficerBeverly Hills, CA
Manish SinghDirectorFremont, CA
Manish SinghExecutive OfficerFremont, CA
Sanford HillsbergDirectorWOODLAND HILLS, CA
Mark J AhnDirectorPortland, OR

Other filings by this issuer (7)

FiledFormOfferingSold
2016-06-15D$100.0M$100.0M
2013-11-15D$23.3M$23.3M
2013-06-06D$1.4M$1.4M
2011-05-03D$1.0M$500K
2011-01-21D$640K$640K
2010-11-08D$250K$250K
2010-10-01D$500K$500K

More